Journal of Pharmaceutical Investigation

Papers
(The H4-Index of Journal of Pharmaceutical Investigation is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Development of prediction model with machine learning in continuous twin screw granulation213
Applications of mesoporous silica particles in amorphous solid dispersion210
Nitric oxide-releasing albumin/chondroitin sulfate bioadhesive dressing for the treatment of MRSA-infected wounds106
Effects of telmisartan and perindopril combination on hypertension and cardiovascular damage83
Enhanced oral bioavailability of pranlukast by preparing amorphous solid dispersion via hot-melt extrusion71
The combination of HDACi encapsulated liposomal vaccines with oncolytic peptide QR-KLU induces an immune-mediated abscopal effect for cancer immunotherapy61
Recent advances in 3D cell culture models in cancer drug development46
Recent advances in Alzheimer’s disease pathogenesis and therapeutics from an immune perspective36
Biocompatible biodegradable polymeric nanocarriers in dry powder inhalers (DPIs) for pulmonary inhalation delivery34
Comprehensive review in continuous direct compression process34
uPAR-targeted senolytic delivery to enhance cancer therapy32
Pharmacokinetic modulation of substrate drugs via the inhibition of drug-metabolizing enzymes and transporters using pharmaceutical excipients30
Lyophilization of pharmaceuticals: an overview and practical approaches for developing the lyophilization cycle27
Organic clay-based fast dissolving microneedles for efficient transdermal delivery of therapeutic proteins27
Self-amplifying ROS nanoplatform with dual responsiveness for tumor-targeted photodynamic therapy26
Enhanced oral delivery of fenofibrate using PEGylated solid lipid nanoparticles25
Prediction of the pharmacokinetics of the GLP-1 receptor agonist semaglutide in humans via a population pharmacokinetic model integrating interspecies scaling25
Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals24
Formulation of secretome derived from mesenchymal stem cells for inflammatory skin diseases23
A two-step design of experiments approach to investigate the simultaneous effects of ion-pairing and chemical enhancers to improve the permeability of lornoxicam in a topical hydrogel patch23
An approach for identifying in silico peptides against authentic metabolites: in vitro characterization of thymosin β4 metabolites21
Theranostic potential and safety assessment of epirubicin-loaded SPIONs/PLGA-PEG nanoparticles in rabbit21
0.17771601676941